Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence SMNANTITK
Primary information
sequence IDSeq_7394
Peptide sequenceSMNANTITK
CancerPDF_ID CancerPDF_ID12217, CancerPDF_ID12666, CancerPDF_ID13505,
PMID26992070,26992070,20974924
Protein NameU4/U6.U5 tri-snRNP-associated protein 1,U4/U6.U5 tri-snRNP-associated protein 1,U4/U6.U5 tri-snRNP-associated protein 1
UniprotKB Entry NameSNUT1_HUMAN,SNUT1_HUMAN,SNUT1_HUMAN
FluidSerum,Serum,Plasma
M/Z978.48043,NA,979.488
ChargeNA,NA,2
Mass (in Da)979.4878406,995.4827136,NA
fdrNA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS
Peptide Identification techniqueLC-MS/MS,LC-MS/MS,LC-MS/MS
Quantification TechniqueNA,NA,NA
Labelled/Label FreeLabel Free,Label Free,Label Free
FDRFDR 1 %,FDR 1 %,NA
CancerPDF_ID CancerPDF_ID12217, CancerPDF_ID12666, CancerPDF_ID13505,
p-ValueNA,NA,NA
SoftwareSEQUEST and Maxquant,"Maxquant,Proteome Discoverer",MASCOT and SEQUEST
Length7,7,NA
Cancer TypeMelanoma,Melanoma,"Multiple myeloma patients, Acute myeloid leukemia"
DatabaseSwissProt Database,SwissProt Database,Uniprot database
ModificationNA,NA,NA
Number of Patients8 cancer samples and 4 healthy samples,8 cancer samples and 4 healthy samples,NA
Regulation"Present in 5 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples.","Present in 5 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples.",NA
Validationna,NA,NA
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasNA
IEDB